#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Androgenetic Alopecia – Current Treatment Options


Authors: R. Litvik
Authors‘ workplace: Kožní oddělení Lékařské fakulty Ostravské univerzity a FN Ostrava primářka MUDr. Yvetta Vantuchová, Ph. D
Published in: Čes-slov Derm, 99, 2024, No. 5, p. 191-198
Category: Reviews (Continuing Medical Education)

Overview

Androgenetic alopecia is a type of progressive, hereditary, non-scaring, androgen-dependent hair loss. It ranks among the most common hair-affecting conditions in general. A complex approach to the issue of androgenetic alopecia guarantees optimal therapeutic response with a positive influence on the quality of life of patients with androgenetic alopecia.

Keywords:

androgenetic alopecia – therapy


Sources
  1. ALESSANDRINI, A., STARACE, M., D´OVIDIO, R. et al. Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines. G Ital Dermatol Venereol. 2020, 155(5), p. 622–631.
  2.  AZZOUNI, F., ZEITOUNI, N., MOHLER, J. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders. J Drugs Dermatol., 2013, 12(2), p. e30–35.
  3. CAMACHO, F., RANDALL, V., PRICE, V. Hair and its disorders: biology, pathology and management. 1st edition, London: Martin Dunitz, 2000, p. 123–177, ISBN 1-85317-799-7.
  4.  JANKŮ, Z. Výroba a prodej vlásenkářských příčesků a vlásenek. Bakalářská práce, Technická univerzita v Liberci. 2011. p. 47.
  5. FUKUSHIRO-LOPES, D., HEGEL, A.D., RUSSO, A. et al. Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Front Pharmacol., 2020, 11, p. 577.
  6. KANTI, V. MESSENGER, A., DOBOS, G. et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version. J Eur Acad Dermatol Venereol., 2018, 32(1), p. 11–22.
  7. LI, M., MARUBAYASHI, A., NAKAYA, Y. et al. Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol., 2001, 117(6), p. 1594–1600.
  8. LY, NY., FRUECHTE, S., HORDINSKY, KM. et al. Medical and procedural treatment of androgenetic alopecia – Where are we? J Am Acad Dermatol., 2023, 89(2S), p. 36–39.
  9. MESSENGER, A., RUNDEGREN, J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol.,2004, 150(2), p. 186–194.
  10. OTOMO, S. Hair growth effect of minoxidil. Folia Pharmacol Jpn., 2002, 119, p. 167–174
  11. SHAPIRO, J. Hair loss. 1st edition, London: Martin Dunitz, 2002, p. 8–119, ISBN 1-85317-876-4.

Do redakce došlo dne 17. 9. 2024.

Adresa pro korespondenci: MUDr. Radek Litvik
Kožní oddělení LF OU a FN Ostrava
17. listopadu 1790/5
708 52
Ostrava-Poruba e-mail: radek.litvik@fno.cz

Labels
Dermatology & STDs Paediatric dermatology & STDs
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#